G
George Luta
Researcher at Georgetown University
Publications - 144
Citations - 3345
George Luta is an academic researcher from Georgetown University. The author has contributed to research in topics: Breast cancer & Randomized controlled trial. The author has an hindex of 32, co-authored 124 publications receiving 2748 citations. Previous affiliations of George Luta include Georgetown University Medical Center & Copenhagen University Hospital.
Papers
More filters
Journal ArticleDOI
Predictors of attrition in a smoking cessation trial conducted in the lung cancer screening setting.
Emily Kim,Randi M. Williams,Ellie Eyestone,Marisa Cordon,Laney Smith,Kimberly Davis,George Luta,Eric D. Anderson,Brady McKee,Juan C Batlle,Michael Ramsaier,Judith Howell,Vicky Parikh,Maria Christina Geronimo,Cassandra A. Stanton,Raymond Niaura,David B. Abrams,Kathryn L. Taylor,Tobacco Lung Screening +18 more
TL;DR: In this article, the authors evaluated predictors of attrition in a smoking cessation trial among individuals undergoing low-dose computed tomographic lung cancer screening (LCS), and illuminated several LCS-related factors that contributed to trial attrition.
Journal ArticleDOI
Recent Bioinformatics Advances in the Analysis of High Throughput Flow Cytometry Data
TL;DR: This special issue aims to summarize the current state of bioinformatics research in FCM, to present the most recent developments in analytical tools and to open-up the field to new researchers to bring additional ideas and solutions to current bottlenecks.
Journal ArticleDOI
Long-Term Adaptation Among Adolescent and Young Adult Children to Familial Cancer Risk.
Glynnis A. McDonnell,Beth N. Peshkin,Tiffani A. DeMarco,Susan K. Peterson,Banu Arun,Susan Miesfeldt,Suzanne C. O'Neill,Katherine A. Schneider,Judy Garber,Claudine Isaacs,George Luta,Kenneth P. Tercyak +11 more
TL;DR: Disclosing maternal BRCA+ status did not influence children's lifestyle behavior or adversely affect quality of life long term, and AYAs of BRCa+ mothers were more aware of and interested in genetic risk information.
Journal ArticleDOI
Patient global assessment is elevated by up to 5 of 10 units in patients with inflammatory arthritis who screen positive for fibromyalgia (by FAST4) and/or depression (by MDS2) on a single MDHAQ.
TL;DR: Patient global assessment (PATGL) is a component of rheumatoid arthritis (RA) and spondyloarthritis (SpA) activity indices, reflecting inflammation in selected clinical trial patients as discussed by the authors .
Pre-treatment psychoneurological symptoms and their association with longitudinal cognitive function and quality of life in older breast cancer survivors
Danielle Tometich,Brent J. Small,Judith E. Carroll,Wanting Zhai,George Luta,Xingtao Zhou,Lindsay C. Kobayashi,Tim A. Ahles,Andrew J. Saykin,Jonathan D. Clapp,Heather S.L. Jim,Paul B. Jacobsen,Arti Hurria,Deena Graham,Brenna C. McDonald,Neelima Denduluri,Martine Extermann,Claudine Isaacs,Asma Dilawari,James C. Root,Christine Rini,Jeanne S. Mandelblatt +21 more
TL;DR: Nearly one-fifth of older breast cancer survivors predict psychoneurological symptoms at diagnosis, which, predict clinically me aningful decrements in perceived cognition in the first 24 months post-diagnosis.